Bill > S4430

This bill, the Interagency Patent Coordination and Improvement Act of 2022, aims to establish an Interagency Task Force on Patents between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA). The task force would coordinate efforts to share information and provide technical assistance regarding patents for human drugs and biological products. Key provisions include requiring the USPTO Director to consult with the FDA Commissioner on patent-related decisions, establishing processes for the FDA to share relevant information with the USPTO, and allowing the USPTO to assist the FDA in listing accurate patent information. The bill also mandates a report from the USPTO on the implementation and usefulness of the task force.